|
Autoimmune diseases
Citations 91-100 of 251 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
CNS involvement in hereditary neuropathy with pressure palsies (HNPP)
- B. Tackenberg, J. C. Möller, H. Rindock, S. Bien, N. Sommer, W. H. Oertel, F. Rosenow, K. Schepelmann, H. M. Hamer, and O. Bandmann
Neurology 2006; 67: 2250-2252.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy
- J.M.F. Niermeijer, M. Eurelings, H. Lokhorst, H. Franssen, R. Fijnheer, J. H.J. Wokke, and N. C. Notermans
Neurology 2006; 67: 2076-2079.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Multiple sclerosis and the hygiene hypothesis
- John O. Fleming and Thomas D. Cook
Neurology 2006; 67: 2085-2086.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Neutralizing antibodies hamper IFNß bioactivity and treatment effect on MRI in patients with MS
- P. Soelberg Sorensen, T. Tscherning, H. K. Mathiesen, A. R. Langkilde, C. Ross, M. Ravnborg, and K. Bendtzen
Neurology 2006; 67: 1681-1683.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
CSF tau protein: A new prognostic marker for Guillain-Barré syndrome
- K. Jin, A. Takeda, Y. Shiga, S. Sato, A. Ohnuma, H. Nomura, H. Arai, S. Kusunoki, M. Ikeda, and Y. Itoyama
Neurology 2006; 67: 1470-1472.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
- L. Kappos, C. H. Polman, M. S. Freedman, G. Edan, H. P. Hartung, D. H. Miller, X. Montalban, F. Barkhof, L. Bauer, P. Jakobs, C. Pohl, R. Sandbrink for the BENEFIT Study Group
Neurology 2006; 67: 1242-1249.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia
- Nikolaus R. McFarland, Ivan S. Login, Samuel Vernon, and Ted M. Burns
Neurology 2006; 67: 1308-1309.
[Full text]
[PDF]
- ARTICLES
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
- L. Kappos, A. Traboulsee, C. Constantinescu, J. -P. Erälinna, F. Forrestal, P. Jongen, J. Pollard, M. Sandberg-Wollheim, C. Sindic, B. Stubinski, B. Uitdehaag, and D. Li
Neurology 2006; 67: 944-953.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct
- Kerstin Imrell, Anne-Marie Landtblom, Jan Hillert, and Thomas Masterman
Neurology 2006; 67: 1062-1064.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers
- H. M. Liu, W. J. Hsieh, C. C. Yang, V. C. Wu, and K. D. Wu
Neurology 2006; 67: 1065-1067.
[Abstract]
[Full text]
[PDF]
|
|
